{"schema_version":"secwatch.filing_event.v1","accession":"0000021076-26-000028","form_type":"8-K","ticker":"CLX","cik":"0000021076","company_name":"CLOROX CO /DE/","filed_at":"2026-08-03T20:12:11+00:00","discovered_at":"2026-08-03T20:13:00.347762+00:00","generated_at":"2026-08-03T20:13:15.761848+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Clorox Q4 EPS falls 50% to $1.34; organic sales drop 13% on ERP lapping","bullets":["Net sales $1.95B, down 2% YoY; organic sales down 13% due to ERP transition lapping (~13.5 pts).","Gross margin 41.3%, down 520 bps; impacted by lower volume, GOJO inventory step-up, higher costs.","Diluted EPS $1.34 vs $2.68; adjusted EPS $1.66 vs $2.87, both down ~50% and 42% respectively.","Completed GOJO acquisition in April 2026; added ~10 points to net sales in Q4.","FY27 outlook: challenging environment expected; no quantitative guidance provided."],"urls":{"canonical":"https://secwatch.observer/filing/0000021076-26-000028","json":"https://secwatch.observer/filing/0000021076-26-000028.json","markdown":"https://secwatch.observer/filing/0000021076-26-000028.md","text":"https://secwatch.observer/filing/0000021076-26-000028.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/21076/000002107626000028/0000021076-26-000028-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/21076/000002107626000028/clx-20260803.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T20:13:15.761848+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}